ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Donepezil Improves Gait Performance in Older Adults with Mild Alzheimer's Disease: A Phase II Clinical Trial
Journal of Alzheimer s Disease
◽
10.3233/jad-140759
◽
2014
◽
Vol 43
(1)
◽
pp. 193-199
◽
Cited By ~ 34
Author(s):
Manuel Montero-Odasso
◽
Susan W. Muir-Hunter
◽
Afua Oteng-Amoako
◽
Karen Gopaul
◽
Anam Islam
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Older Adults
◽
Alzheimer's Disease
◽
Clinical Trial
◽
Phase Ii
◽
Phase Ii Clinical Trial
◽
Gait Performance
Download Full-text
Related Documents
Cited By
References
P2-027: TARGET ENGAGEMENT IN A PHASE II CLINICAL TRIAL OF AAV2-NGF GENE THERAPY FOR ALZHEIMER'S DISEASE
Alzheimer s & Dementia
◽
10.1016/j.jalz.2018.06.711
◽
2006
◽
Vol 14
(7S_Part_12)
◽
pp. P677-P677
Author(s):
Michael J. Castle
◽
Fernando Calvo Baltanas
◽
Imre Kovacs
◽
Alan H. Nagahara
◽
Krystof S. Bankiewicz
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trial
◽
Gene Therapy
◽
Phase Ii
◽
Phase Ii Clinical Trial
◽
Target Engagement
◽
Ngf Gene
Download Full-text
P4-016: MCLENA-1: A PHASE II CLINICAL TRIAL FOR THE ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LENALIDOMIDE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE; TRIAL DESIGN AND RATIONALE
Alzheimer s & Dementia
◽
10.1016/j.jalz.2019.06.3675
◽
2019
◽
Vol 15
◽
pp. P1279-P1279
Author(s):
Boris Decourt
◽
Nadia Fulkerson
◽
Alana Burns
◽
Garam Lee
◽
Tessa St Rose
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trial
◽
Cognitive Impairment
◽
Mild Cognitive Impairment
◽
Phase Ii
◽
Trial Design
◽
Phase Ii Clinical Trial
Download Full-text
PHASE II CLINICAL TRIAL WITH AN AMPA-POSITIVE ALLOSTERIC MODULATOR (S 47445): BASELINE DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS SUFFERING FROM ALZHEIMER’S DISEASE AT MILD TO MODERATE STAGES WITH DEPRESSIVE SYMPTOMS
Alzheimer s & Dementia
◽
10.1016/j.jalz.2017.07.195
◽
2017
◽
Vol 13
(7)
◽
pp. P575
◽
Cited By ~ 1
Author(s):
Jeffrey L. Cummings
◽
Katy Bernard
◽
Sylvie Bretin
◽
Sylvie Gouttefangeas
◽
Maria Pueyo
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trial
◽
Depressive Symptoms
◽
Phase Ii
◽
Clinical Characteristics
◽
Phase Ii Clinical Trial
◽
Allosteric Modulator
◽
Positive Allosteric Modulator
◽
Baseline Demographic
Download Full-text
Phase II Clinical Trial of Nicotinamide for the Treatment of Mild to Moderate Alzheimer's Disease
Journal of Geriatric Medicine and Gerontology
◽
10.23937/2469-5858/1510021
◽
2017
◽
Vol 3
(1)
◽
Cited By ~ 9
Author(s):
Michael J Phelan
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trial
◽
Phase Ii
◽
Phase Ii Clinical Trial
Download Full-text
MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease
Open Access Journal of Clinical Trials
◽
10.2147/oajct.s221914
◽
2020
◽
Vol Volume 12
◽
pp. 1-13
◽
Cited By ~ 1
Author(s):
Boris Decourt
◽
Jeffrey Wilson
◽
Aaron Ritter
◽
Christopher Dardis
◽
Frank DiFilippo
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trial
◽
Cognitive Impairment
◽
Mild Cognitive Impairment
◽
Phase Ii
◽
Phase Ii Clinical Trial
Download Full-text
O4-06-05: PF-04447943: A phase II controlled clinical trial of a selective PDE9A inhbitor in Alzheimer's disease
Alzheimer s & Dementia
◽
10.1016/j.jalz.2011.05.2009
◽
2011
◽
Vol 7
◽
pp. S695-S695
◽
Cited By ~ 6
Author(s):
Elias Schwam
◽
Rebecca Evans
◽
Timothy Nicholas
◽
Robert Chew
◽
Wendy Davidson
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trial
◽
Phase Ii
◽
Controlled Clinical Trial
Download Full-text
P3-037: CLINICAL TRIAL DESIGN FOR A PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF AMX0035 IN ALZHEIMER'S DISEASE
Alzheimer s & Dementia
◽
10.1016/j.jalz.2018.06.1392
◽
2006
◽
Vol 14
(7S_Part_20)
◽
pp. P1078-P1079
Author(s):
Kent L. Leslie
◽
Joshua Cohen
◽
Justin Klee
◽
Victoria Williams
◽
Steven E. Arnold
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trial
◽
Phase Ii
◽
Trial Design
◽
Controlled Trial
◽
Clinical Trial Design
Download Full-text
P4-023: CLINICAL TRIAL DESIGN FOR A PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF AMX0035 IN ALZHEIMER'S DISEASE
Alzheimer s & Dementia
◽
10.1016/j.jalz.2019.06.3682
◽
2019
◽
Vol 15
◽
pp. P1282-P1283
Author(s):
Kent L. Leslie
◽
Justin Klee
◽
Joshua Cohen
◽
Victoria J. Williams
◽
Suzanne B. Hendrix
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trial
◽
Phase Ii
◽
Trial Design
◽
Controlled Trial
◽
Clinical Trial Design
Download Full-text
P4-358: Effectiveness of collaborative care for older adults with Alzheimer's disease in primary care: A clinical trial
Alzheimer s & Dementia
◽
10.1016/j.jalz.2006.05.2099
◽
2006
◽
Vol 2
◽
pp. S622-S622
Author(s):
Christopher M. Callahan
◽
Malaz A. Boustani
◽
Frederick W. Unverzagt
◽
Mary G. Austrom
◽
Teresa A. Damush
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Older Adults
◽
Primary Care
◽
Alzheimer's Disease
◽
Clinical Trial
◽
Collaborative Care
Download Full-text
A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease
Journal of Alzheimer s Disease
◽
10.3233/jad-142499
◽
2015
◽
Vol 45
(2)
◽
pp. 395-405
◽
Cited By ~ 52
Author(s):
Ruth Remington
◽
Cynthia Bechtel
◽
David Larsen
◽
Annemarie Samar
◽
Laura Doshanjh
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trial
◽
Randomized Clinical Trial
◽
Phase Ii
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close